Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.69 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.69 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.52 |
| ▸ | CD40 | P25942 | 1/20 | 0.50 |
| ▸ | CD40LG | P29965 | 1/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.48 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4166597 | 1.00 | PRMT1 (0.69) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL13881052 | 0.94 | PRMT1 (0.60) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL9412036 | 0.90 | PRMT1 (0.55) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL3692866 | 0.87 | PRMT1 (0.56) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL18232417 | 0.86 | PRMT1 (0.51) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL3691652 | 0.85 | FUT8 (0.69) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL3691645 | 0.85 | FUT8 (0.69) | PRMT1CARM1FUT8CD40CD40LG | |
| SCHEMBL8972359 | 0.85 | CD40 (0.56) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL71170 | 0.85 | CD40 (0.56) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL10343440 | 0.85 | CD40 (0.56) | PRMT1CARM1CD40CD40LGENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367823-B2 | Colorants based N-halamines compositions and method of making and using | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-02-05 | — | — | US | disclosed |
| EP-2201069-A2 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | Board of Regents, The University of Texas System (US) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009039180-A2 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-03-26 | — | — | WO | disclosed |
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-03-19 | — | — | US | disclosed |
| US-5197992-A | Disazo dye, naphthol dye with triazole groups for wool, silk, polyamides and cellulose with triphenodioxazines | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-03-30 | — | — | US | disclosed |
| US-5196033-A | BIS-azotriazinyl reactive dyes having an N-alkyl-phenylenediamine link for cellulose textiles | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-03-23 | — | — | US | disclosed |
| US-5059681-A | BIS-AZOTRIAZINYL REACTIVE DYES HAVING AN N-ALKYL-PHENYLENEDIAMINE LINK | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | TYR, MPO, NISCH | PRMT1 949/4885CARM1 988/4885FUT8 651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.